• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种原发性人类肿瘤中假定癌基因PRAD1/细胞周期蛋白D1过表达转录本的编码序列。

Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.

作者信息

Rosenberg C L, Motokura T, Kronenberg H M, Arnold A

机构信息

Endocrine Unit, Massachusetts General Hospital, Boston 02114.

出版信息

Oncogene. 1993 Feb;8(2):519-21.

PMID:8426754
Abstract

PRAD1 (cyclin D1) is a recently identified member of the family of cyclin genes, believed to play roles in regulating transitions through the cell cycle. The PRAD1 gene, located at 11q13, has been implicated in the pathogenesis of a variety of tumors, including parathyroid adenomas, t(11;14) bearing B-lymphoid tumors (particularly centrocytic lymphomas) where it is highly likely to be the BCL1 oncogene, and possibly in breast carcinomas and squamous cell cancers of the head and neck as well. PRAD1's tumorigenic influence appears to be effected through overexpression of its normal-sized transcript, but it has not been established whether the transcript's coding sequence is normal or contains oncogenic mutations. We have sequenced the coding region of the overexpressed PRAD1 transcript from two primary tumors with clonal PRAD1 region rearrangements: a benign parathyroid adenoma and a malignant centrocytic lymphoma. Each sequence is identical to the normal PRAD1 cDNA sequence, and presumably encodes normal PRAD1 protein. Thus, PRAD1 likely functions as a direct-acting oncogene whose rearrangement in tumors leads to overexpression or deregulated expression of its normal protein product.

摘要

PRAD1(细胞周期蛋白D1)是细胞周期蛋白基因家族中最近发现的成员,被认为在调节细胞周期转换中发挥作用。PRAD1基因位于11q13,与多种肿瘤的发病机制有关,包括甲状旁腺腺瘤、携带t(11;14)的B淋巴细胞肿瘤(特别是中心细胞淋巴瘤),在这些肿瘤中它很可能是BCL1癌基因,也可能与乳腺癌以及头颈部鳞状细胞癌有关。PRAD1的致瘤影响似乎是通过其正常大小转录本的过表达实现的,但尚未确定该转录本的编码序列是正常的还是包含致癌突变。我们对来自两个具有克隆性PRAD1区域重排的原发性肿瘤(一个良性甲状旁腺腺瘤和一个恶性中心细胞淋巴瘤)中过表达的PRAD1转录本的编码区进行了测序。每个序列都与正常的PRAD1 cDNA序列相同,推测编码正常的PRAD1蛋白。因此,PRAD1可能作为一种直接作用的癌基因,其在肿瘤中的重排导致其正常蛋白产物的过表达或表达失调。

相似文献

1
Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.两种原发性人类肿瘤中假定癌基因PRAD1/细胞周期蛋白D1过表达转录本的编码序列。
Oncogene. 1993 Feb;8(2):519-21.
2
Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism.人类乳腺癌和甲状旁腺腺瘤中细胞周期蛋白D1/PRAD1点突变的缺失以及一种新的细胞周期蛋白D1基因多态性的鉴定。
Cancer Lett. 1995 Jul 13;93(2):165-70. doi: 10.1016/0304-3835(95)03805-7.
3
PRAD1 (cyclin D1): a parathyroid neoplasia gene on 11q13.PRAD1(细胞周期蛋白D1):位于11号染色体长臂13区的甲状旁腺肿瘤基因。
Henry Ford Hosp Med J. 1992;40(3-4):177-80.
4
A novel cyclin encoded by a bcl1-linked candidate oncogene.一种由bcl1相关候选癌基因编码的新型细胞周期蛋白。
Nature. 1991 Apr 11;350(6318):512-5. doi: 10.1038/350512a0.
5
Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.伴有t(11;14)(q13;q32)易位的淋巴恶性肿瘤中PRAD1的基因重排与过表达。
Oncogene. 1992 Jul;7(7):1401-6.
6
PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.PRAD1/细胞周期蛋白D1原癌基因:基因组结构、5'端DNA序列及肿瘤特异性重排断裂点序列
Genes Chromosomes Cancer. 1993 Jun;7(2):89-95. doi: 10.1002/gcc.2870070205.
7
Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.中心细胞淋巴瘤中位于PRAD1/细胞周期蛋白D1基因位点的11号染色体易位断点。
Leukemia. 1993 Feb;7(2):241-5.
8
Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.中心细胞淋巴瘤中11号染色体在bcl-1和PRAD1基因座易位断点的特征分析。
Cancer Res. 1992 Oct 1;52(19 Suppl):5541s-5544s.
9
Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.在人类癌症中,于扩增的染色体11q13区域内鉴定并克隆出两个过表达基因,即U21B31/PRAD1和EMS1。
Oncogene. 1992 Feb;7(2):355-61.
10
The cyclin D1/PRAD1 oncogene in human neoplasia.人类肿瘤中的细胞周期蛋白D1/PRAD1癌基因。
J Investig Med. 1995 Dec;43(6):543-9.

引用本文的文献

1
Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.RB缺失的综合多组学分析揭示了广泛的细胞编程和合成弱点。
Commun Biol. 2021 Aug 17;4(1):977. doi: 10.1038/s42003-021-02495-2.
2
Molecular analysis of cyclin D1 modulators PRKN and FBX4 as candidate tumor suppressors in sporadic parathyroid adenomas.细胞周期蛋白D1调节因子PRKN和FBX4作为散发性甲状旁腺腺瘤候选肿瘤抑制因子的分子分析
Endocr Connect. 2021 Mar;10(3):302-308. doi: 10.1530/EC-21-0055.
3
D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.
D 型细胞周期蛋白是细胞因子信号的重要下游效应物,可调节正常和肿瘤性乳腺上皮细胞的增殖。
Mol Cell Endocrinol. 2014 Jan 25;382(1):583-592. doi: 10.1016/j.mce.2013.03.016. Epub 2013 Apr 4.
4
Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia.转基因小鼠揭示了转化生长因子α和表皮生长因子受体在乳腺发育和肿瘤形成中的作用。
J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):119-29. doi: 10.1023/a:1026347629876.
5
Cyclin D1 and human neoplasia.细胞周期蛋白D1与人类肿瘤
Mol Pathol. 1998 Feb;51(1):1-7. doi: 10.1136/mp.51.1.1.
6
Function of a human cyclin gene as an oncogene.一种人类细胞周期蛋白基因作为癌基因的功能。
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):709-13. doi: 10.1073/pnas.91.2.709.
7
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.细胞周期蛋白D1/bcl-1与myc基因协同作用,在转基因小鼠中引发B细胞淋巴瘤。
EMBO J. 1994 Aug 1;13(15):3487-95. doi: 10.1002/j.1460-2075.1994.tb06655.x.
8
Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.细胞周期蛋白D1(Bcl-1、PRAD1)在低度B细胞淋巴瘤和反应性增生中的蛋白表达
Am J Pathol. 1994 Jul;145(1):86-96.
9
Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.散发性甲状旁腺增生和肿瘤性病变中RET原癌基因点突变的缺失
Am J Pathol. 1995 Dec;147(6):1600-7.